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T cell clonal expansion and differentiation to effector cells 
are the hallmarks of adaptive immune responses (Kaech et 
al., 2002; Williams and Bevan, 2007). Although the initiation of 
clonal expansion and differentiation results in fundamental 
changes in the cellular function of naive T cells, in the course 
of responses to infection, activated T cells display extraordinary 
diversification in proliferation, differentiation, and the devel-
opment of memory cells resulting from changes in external 
signals in the microenvironment such as antigens, inflamma-
tion, and co-stimulation (Buchholz et al., 2013; Gerlach et 
al., 2013). The adjustment of individual T cells in response to 
changes in external signals is important to achieve a robust 
response while controlling immunopathology (Buch holz et 
al., 2013; Gerlach et al., 2013). TCR signaling is required for 
activation and cell cycle progression leading to rapid clonal 
expansion (Kaech et al., 2002; Williams and Bevan, 2007). 
However, functional differentiation is induced by a combi-
nation of signals including antigens, inflammatory conditions, 
and cytokines, which induce differentiation programs regu-
lated by transcription factors such as T-bet, Eomes, Runx2, 
Runx3, Id2, Id3, and BLI MP-1, leading to the acquisition 
of specific functions including cytotoxicity for CD8 T cells 
and Th function for CD4 cells, and also to form memory T 
cells (Kaech and Cui, 2012). Most of the known regulators 
important for adaptive responses of T cells affect both clonal 
expansion and effector differentiation (Kaech and Cui, 2012). 
Therefore, clonal expansion is considered to be coupled with 
effector differentiation and the development of memory. 
Findings from individual transcription factors involved in 
effector differentiation such as T-bet demonstrate that clonal 
expansion and differentiation are regulated by transcrip-
tional networks rather than by individual transcription 
factors (Intlekofer et al., 2005). In addition, the diversity in 
clonal expansion and differentiation of individual T cells 
carrying the same TCR (Buchholz et al., 2013; Gerlach 
et al., 2013) indicates that there may be upstream regula-
tors controlling clonal expansion and differentiation based 
on signals encountered in the microenvironment during 
adaptive immune responses.
Egr2 and 3 are closely related members of the Egr zinc 
finger transcription factor family with important roles in 
controlling the self-tolerance of lymphocytes and the devel-
opment of NKT cells (Harris et al., 2004; Safford et al., 2005; 
Anderson et al., 2006; Lazarevic et al., 2009). Egr2 and 3 are 
induced in both naive and tolerant T cells (Harris et al., 2004; 
Safford et al., 2005; Anderson et al., 2006). The importance of 
Egr2 and 3 in controlling the development of autoimmunity 
was discovered in aged CD2-specific Egr2-deficient mice 
and in CD2-specific Egr2- and Egr3-deficient mice (Zhu 
et al., 2008; Li et al., 2012). Interestingly, despite increased 
homeostatic proliferation, and in contrast to findings from 
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Figure 1. Egr2 and 3 suppress activation but are required for clonal expansion of t cells. WT and CD2-Egr2/3−/− (K2-3) mice were infected with 
OVA-VVWR i.n. (A and B) 7 d after infection, CD4 and CD8 T cells from spleen and lymph nodes were analyzed for CD62L and CD44 or CD44 and Egr2 
expression (A) and Egr3 expression (B) by RT-PCR. (C) Activation phenotypes of CD4 and CD8 T cells from WT, K2-3, and CD2-Egr2 transgenic (Tg) mice. 
(D) T cell numbers before and after viral infection in WT, K2-3, and Tg mice (left) and fold expansion after infection (right). (E and F) Cells from spleen and 
lymph nodes of infected WT, K2-3, and Tg mice were analyzed for Ki67 and CD44 expression on gated CD4 and CD8 cells, with the percentages of Ki67+ 
cells among the CD44high population indicated in parentheses (E); and the percentages of Ki67+ cells among CD44high cells were analyzed (F). (G) Kb-SII NFE KL 
1789JEM Vol. 214, No. 6
Egr2-transfected T cell lines (Safford et al., 2005), Egr2 or 3 
single-deficient T cells respond normally to TCR stimulation 
in vitro (Zhu et al., 2008; Li et al., 2012), whereas prolifera-
tion of Egr2- and Egr3-deficient T cells is impaired (Li et al., 
2012). Egr2 and 3 are highly induced in naive T cells at the 
early stages of responses to infection and antigen stimulation 
in vivo (Anderson et al., 2006; Best et al., 2013), suggest-
ing that Egr2 and 3 may regulate T cell–mediated adaptive 
immune responses. Recently, Egr2 was found to be import-
ant for differentiation of T cells in response to viral infec-
tion by directly binding to the Tbx21 locus and promoting 
the expression of T-bet (Du et al., 2014). However, defective 
responses to viral infection were not observed in a similar 
model from another study (Ramón et al., 2010).
Here, we discovered a fundamental and overlapping 
function of Egr2 and 3 for temporally uncoupling clonal ex-
pansion from differentiation of viral responding T cells. T cells 
that lack Egr2 and 3 were severely impaired in expansion but 
displayed excessive inflammatory responses, resulting in severe 
inflammatory pathology but poor viral clearance. In contrast, 
forced expression of Egr2 significantly increased clonal ex-
pansion, but the expanded T cells failed to differentiate. Egr2 
and 3 were rapidly induced in naive T cells by antigen and 
promptly inhibited by IFNγ through an inhibitory feedback 
mechanism, which allows optimal clonal expansion and cou-
pling of expansion with effector differentiation. Egr2 and 3 
directly promoted expression of proliferation regulators (Myc 
and Myb) and differentiation repressors (Bcl6 and Id3) but 
suppressed transcription factors involved in effector differen-
tiation (Zeb2, Bhlhe40, RORa, and RORc). Thus, temporally 
regulated expression of Egr2 and 3 induced in naive T cells 
in response to virus infection is essential for optimal adaptive 
immune responses with minimum pathology.
rEsults
Egr2 and 3 reciprocally control the activation and 
clonal expansion of t cells
Egr2 and 3 are induced in naive T cells by infection or an-
tigen stimulation in vivo (Anderson et al., 2006; Best et al., 
2013). To investigate the role of Egr2 and 3 in T cells in anti-
viral responses, we infected WT, CD2-Egr2 transgenic and 
CD2-Egr2/3−/− mice aged between 7 and 8 wk i.n. with 
vaccinia virus encoding OVA (OVA-VVWR). After backcross-
ing more than 30 times to the C57BL/6 background, T cells 
from 8-wk-old CD2-Egr2/3−/− mice showed levels of effec-
tor phenotype T cells similar to those in WT mice (Fig. 1 A). 
Therefore, we used young mice (7–8 wk) that did not show 
signs of autoimmunity throughout this study. Egr2 and 3 were 
barely detectable in T cells from naive WT mice (Fig. 1, A and 
B). 7 d after infection with OVA-VVWR, Egr2 was induced 
in CD44high T cells (Fig. 1 A). Induction of Egr3 was also de-
tected in CD8 T cells from infected WT mice (Fig. 1 B). The 
induction of Egr2 expression in activated CD4 and CD8 T 
cells was further demonstrated by coexpression of CD69 with 
Egr2 in CD4 and CD8 T cells from virus-infected WT mice 
(Fig. 1 C). Although ∼40% of CD8 T cells in WT mice were 
CD44high, the proportion of CD44high cells was more than 
75% in CD2-Egr2/3−/− mice but less than 15% in CD2-Egr2 
transgenic mice (Fig. 1 C). Similar expression patterns were 
seen for CD69 and CD44 in CD4 T cells (Fig. 1 C), indicat-
ing that Egr2 and 3 are not required for but control T cell ac-
tivation. Although the numbers of T cells in naive CD2-Egr2 
transgenic and CD2-Egr2/3−/− mice were lower than in WT 
mice (Li et al., 2011, 2012), the expansion of T cells in infected 
CD2-Egr2/3−/− mice was severely defective, whereas expan-
sion was enhanced in CD2-Egr2 transgenic mice (Fig. 1 D). 
Although ∼70% of CD44high T cells in WT mice expressed 
Ki67, less than a third of CD44high T cells in CD2-Egr2/3−/− 
mice expressed this proliferation marker (Fig.  1, E and F). 
Interestingly, despite the decreased proportion of CD44high 
T cells in CD2-Egr2 transgenic mice, ∼90% of this popula-
tion expressed Ki67 (Fig. 1, E and F). Consistent with this dif-
ferential proliferation, the number of Kb-SII NFE KL–specific 
CD8 T cells in infected CD2-Egr2/3−/− mice was only ∼105 
compared with ∼12 × 105 in CD2-Egr2 transgenic mice and 
∼6 × 105 in WT mice (Fig. 1 G). Thus, Egr2 and 3, induced 
in activated T cells, control T cell activation but also promote 
clonal expansion of virus-specific T cells.
Egr2 and 3 suppress differentiation of effector t cells
Clonal expansion is suggested to be coupled with effector 
differentiation in T cell adaptive immune responses (Kaech 
et al., 2002; Williams and Bevan, 2007). We have now shown 
that Egr2 and 3 are required for clonal expansion. Therefore, 
we assessed the differentiation of effector CD4 and CD8 
T cells in response to viral infection by analysis of produc-
tion of effector cytokines and granzyme B. We discovered 
that Egr2 and 3 promoted clonal expansion but profoundly 
suppressed differentiation of effector CD4 and 8 T cells. 
Although their clonal expansion was severely impaired, 
Egr2- and Egr3-deficient CD4 and CD8 T cells were hyper-
differentiated during antiviral responses, as indicated by the 
percentages of IFNγ-producing CD4 cells and IFNγ-, TNF-, 
and granzyme Β–producing CD8 T cells, which were more 
than double those in WT counterparts (Fig. 2, A–C). In con-
trast, the expression of effector cytokines by CD4 and CD8 
T cells in infected CD2-Egr2 transgenic mice was less than 
a third of that from WT counterparts (Fig. 2, A–C), indicat-
ing that clonal expansion was largely uncoupled from effec-
tor differentiation in infected CD2-Egr2 transgenic mice. We 
tetramer–positive CD8 cells from spleen and lymph nodes of WT, K2-3, and Tg mice 7 d after infection. Data in A–G are from pooled cells of five mice of each 
genotype and are representative of three independent experiments. Data in B are means ± SD, and data in D, F, and G are means ± SEM and were analyzed 
with Kruskal–Wallis tests, followed by Conover tests with Benjamini–Hochberg correction. N.S., not significant; **, P < 0.01.
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Figure 2. Egr2 and 3 control differentiation of effector t cells. WT, CD2-Egr2/3−/− (K2-3), and CD2-Egr2 transgenic (Tg) mice were infected with 
OVA-VVWR i.n. and analyzed 7 d after infection. (A) CD4 and CD8 cells from spleen and lymph nodes of uninfected and infected mice were incubated 
with virus-infected LB27.4 cells for 16 h before analysis of IFNγ- and TNF-producing cells. (B) Granzyme B–producing CD8 cells from spleen and lymph 
nodes of infected mice were analyzed after in vitro stimulation as in A. (C) CD8 cells were isolated from spleens of infected mice and incubated with 
virus- infected LB27.4 cells for 16 h in vitro. CD8+Kb-SII NFE KL-tetramer+ cells (left) were analyzed for IFNγ and TNF production (right). (D) CD8 T cells among 
lung-infiltrating lymphocytes from infected mice were gated for analysis of proliferation and production of cytokines. The percentages of Ki67+ cells among 
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also found that lung CD8 cells from infected CD2-Egr2/3−/− 
mice had decreased Ki67 expression but increased IFNγ and 
TNF expression compared with lung CD8 cells from infected 
WT mice (Fig. 2 D) consistent with the results from lym-
phoid organs. These findings demonstrate a novel and funda-
mental function of Egr2 and 3 for promoting expansion 
while inhibiting differentiation, and indicate that Egr2 and 
3 function has to be regulated for optimal coupling of clonal 
expansion with differentiation of effector cells.
controlled expression of Egr2 and 3 in t cells is essential 
for antiviral responses
Although CD2-Egr2/3−/− and CD2-Egr2 mice had opposite 
patterns of clonal expansion and differentiation, both lines had 
more severe infection than WT mice (Fig. 2 E) with impaired 
viral clearance (Fig.  2  F). However, the immunopathology 
in infected lungs was altered distinctively in CD2-Egr2/3−/− 
and CD2-Egr2 transgenic mice. CD2-Egr2/3−/− mice had 
severe inflammatory pathology in the lungs after i.n. infec-
tion with OVA-VVWR (Fig. 2 G), whereas lung inflammation 
and mononucleocyte infiltration in infected lungs were much 
milder in CD2-Egr2 transgenic mice compared with WT 
counterparts (Fig. 2 G). The reciprocally altered lung immu-
nopathology mirrored the reciprocal alterations in T cell ac-
tivation and differentiation in these mice, demonstrating that 
dysregulated expression of Egr2 and 3 in T cells results in 
impaired adaptive immune responses.
overlapping role of Egr2 and 3 in the 
control of t cell responses
To determine whether the altered responses of CD2-Egr2/3−/− 
mice are caused by deficiency in Egr2, Egr3, or both, we an-
alyzed mice with a single defect in either Egr2 or Egr3 in T 
cells. T cells with a single defect in either Egr2 or Egr3 did not 
have significant changes in expansion, proliferation, activation 
markers, or differentiation in response to viral infection (Fig. 3, 
A–C). Furthermore, mice with a single defect in either Egr2 
or Egr3 in T cells did not have impaired responses to viral in-
fection (Fig. 3, D and E). Collectively, these results demonstrate 
that the altered responses of CD2-Egr2/3−/− mice are caused 
by deficiency in both Egr2 and Egr3, indicating an overlapping 
function of Egr2 and 3 in the control of T cell responses.
the function of Egr2 and 3 is t cell intrinsic
To assess whether the function of Egr2 and 3 during anti viral 
responses is T cell intrinsic, we generated chimeras by recon-
stitution of irradiated WT mice with an equal number of BM 
cells from WT and CD2-Egr2/3−/− mice. Consistent with 
CD2-Egr2/3−/− mice, Egr2- and Egr3-deficient T cells in the 
chimeras displayed impaired expansion and enhanced differ-
entiation in response to viral infection (Fig.  4, A–C). How-
ever, T cells from WT BM showed normal responses in terms 
of expansion and differentiation (Fig.  4, A–C). To exclude 
the influence of developmental defects (Li et al., 2011, 2012) 
on the function of Egr2/3 deficient T cells, and to analyze 
antigen- specific responses, we generated OT1 retrogenic mice 
by reconstituting irradiated C57BL/6 mice with BM cells from 
either WT or CD2-Egr2/3−/− mice after transduction with an 
OT1 TCRα and β retroviral construct, which also carries a 
GFP marker (Holst et al., 2006a,b). Naive WT and Egr2/3−/− 
retrogenic OT1 cells were isolated and adoptively transferred to 
separate naive WT mice. GFP+CD8+Kb-SII NFE KL-tetramer+ 
retrogenic OT1 cells were analyzed before and after in-
fection in recipient mice. Consistent with the results from 
CD2-Egr2/3−/− mice, Egr2/3-deficient retrogenic OT1 cells 
had severe defects in proliferation but were highly activated and 
produced excessive levels of effector cytokines compared with 
WT retrogenic-OT1 cells in response to OVA-VVWR infec-
tion (Fig. 4, D–G). These results demonstrate that the reciprocal 
defects in clonal expansion and differentiation of Egr2- and 
Egr3-deficient T cells in adaptive immune responses are cell 
intrinsic and not a result of developmental defects.
To further assess the intrinsic function of Egr2 and 3 in T 
cells during antiviral responses, we created GFP-Egr2 knock-in 
mice (Fig. 5, A–C). GFP was fused to the N terminus of Egr2, 
which does not affect the interaction of Egr2 with its target 
DNA (Fig. 5 D) or Egr2 function, as indicated by restored func-
tion of Egr2- and Egr3-deficient T cells after transduction with 
lentivirus carrying the GFP-Egr2 fusion gene (Fig. 5 E). Con-
sistent with WT mice, high levels of GFP-Egr2 were detected 
in CD44high T cells in response to viral infection (Fig. 5 F). 7 
d after infection, CD44highGFP- Egr2high and CD44highGFP- 
Egr2low cells were assessed for their proliferation and effec-
tor function. CD44highGFP-Egr2high and CD44highGFP- 
Egr2low cells displayed asymmetric responses in terms of pro-
liferation and differentiation, resembling the results from 
CD2-Egr2 transgenic and CD2-Egr2/3−/− mice, respec-
tively. Ki67 was highly expressed in CD44highGFP-Egr2high 
but was low in CD44highGFP-Egr2low cells (Fig.  5  G). 
CD8+CD44highGFP-Egr2high cells underwent strong prolif-
eration, whereas CD8+CD44highGFP-Egr2low cells prolifer-
ated poorly in response to viral antigen stimulation in vitro 
(Fig. 5 H). In response to virus infection, CD44highGFP-Egr2high 
and CD44highGFP-Egr2low T cells produced IL2 and effector 
cytokines differentially, again similar to T cells from CD2-Egr2 
transgenic and CD2-Egr2/3−/− mice. CD44highGFP-Egr2high 
T cells expressed high levels of IL2 but very low IFNγ, whereas 
CD44highGFP-Egr2low cells expressed low levels of IL2 but high 
the CD44high population are indicated in parentheses. (E) Body weight loss of infected mice. (F) Viral titer in lung tissue specimens. (G) H&E staining of lung 
tissues 7 d after infection. Bar, 100 µm. Data in A–D are from pooled cells from five mice of each genotype and are representative of three independent 
experiments. Data in E–G are representative of five independent experiments with four to five mice per group. Data in E and F are means ± SEM and were 
analyzed with Kruskal–Wallis tests, followed by Conover tests with Benjamini–Hochberg correction. *, P < 0.05; **, P < 0.01.
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levels of IFNγ (Fig.  5  I). Similar to the differential produc-
tion of IFNγ, CD8+CD44highGFP-Egr2high cells expressed low 
levels of granzyme B, whereas CD8+CD44highGFP-Egr2low 
cells expressed high levels of granzyme B (Fig.  5  I). Egr3 
expression was higher in CD44highGFP-Egr2high cells than 
CD44highGFP- Egr2low cells (Fig. 5 I), supporting the notion of 
an overlapping function between these two transcription fac-
tors. These results demonstrate that Egr2 and 3 play an intrinsic 
role in controlling clonal expansion and differentiation of T 
cells and confirm that the dysregulated functions of T cells re-
sulting from Egr2 and 3 deficiency or sustained expression of 
Egr2 are not caused by developmental defects.
Egr2 and 3 reciprocally regulate genes involved in 
proliferation and effector differentiation
To investigate the genes regulated by Egr2 and 3 in 
Egr2-expressing T cells in infected mice in vivo, CD44highGFP- 
Egr2high CD4 and CD8 cells from GFP-Egr2 mice and 
CD44high CD4 and CD8 T cells from CD2-Egr2/3−/− mice 
were isolated after viral infection and analyzed by RNA-seq. 
The expression profiles from three independent infection 
experiments showed that more than a third of genes dys-
regulated in CD4 cells were also altered in CD8 T cells and 
vice versa (Fig. 6 A). The genes up-regulated in Egr2- and 
Egr3-deficient T cells were mostly associated with effec-
tor differentiation and function of effector T cells (Table 1, 
Fig. 6 B, and Dataset S1), including lineage-specific transcrip-
tion factors (Tbx21, Runx2, Runx3, Rora, Rorc, Bhlhe40, 
Zeb2, and Prdm1; Kaech and Cui, 2012); genes required 
for effector function (Ifng, Gzma, Gzmb, Gzmk, Csf1, Il17a, 
Il1b, and Il18; Kaech et al., 2002; Williams and Bevan, 2007) 
and migration of effector T cells (Ccl4, Ccr2, Ccr3, and 
Ccr5; Luther and Cyster, 2001); and inhibitors of prolifer-
ation (Mxi1 and Mxd1; Fig.  6 B; Ayer et al., 1993; Zervos 
et al., 1993). In contrast, the down-regulated genes included 
key genes required for T cell expansion (Il2, Myb, Myc, and 
Bcl9; Fig. 6 B; Lieu et al., 2004; Mani et al., 2009; Wang et 
al., 2011; Nie et al., 2012). Interestingly, transcription factors 
known to be involved in T follicular helper (Tfh) cell devel-
opment (Ascl2, Bcl6, Tcf7, Lef1; Nurieva et al., 2009; Yu et 
Figure 3. overlapping function of Egr2 and 3 in control of t cell proliferation and differentiation. WT, CD2-Egr2 knockout (K2), and Egr3 knockout 
(K3) mice were infected with OVA-VVWR i.n. for 7 d. (A–C) CD8 T cells from spleen and lymph nodes were analyzed for expansion (A), activation and prolif-
eration (B), and production of cytokines (C). The percentages of Ki67+ cells among the CD44high population are indicated in parentheses in B. (D and E) Body 
weight loss (D) and lung viral load (E) were measured compared with CD2-Egr2/3−/− (K2-3) mice. A–E are representative of two independent experiments 
with four mice per group. Data in A, D, and E are means ± SEM and were analyzed with Kruskal–Wallis tests, followed by Conover tests with Benjamini–
Hochberg correction. N.S., not significant; *, P < 0.05, **, P < 0.01.
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Figure 4. Egr2 and 3 function is cell intrinsic. (A–C) Irradiated WT mice were adoptively transferred with an equal number of BM cells from WT and 
CD2-Egr2/3−/− (K2-3) mice. 8 wk after transfer, mice were infected with OVA-VVWR and analyzed 7 d after infection. (A) Splenic cells from chimeric mice 
were stained with CD45.1, CD45.2, CD4, and CD8, and the proportion of WT (CD45.1) and K2-3 (CD45.2) CD4 and CD8 cells was determined by flow cytom-
Egr2 and 3 uncouple expansion from differentiation | Miao et al.1794
al., 2009; Liu et al., 2014; Choi et al., 2015; Xu et al., 2015) 
were down-regulated (Fig.  6  B), which is consistent with 
our previous findings that Tfh development is defective in 
Egr2- and Egr3-deficient CD4 T cells (Ogbe et al., 2015). In 
addition, repressors of effector differentiation such Id3 and 
Bcl6 were also down-regulated in Egr2- and Egr3-deficient 
T cells (Shaffer et al., 2000; Yang et al., 2011). Although most 
of the genes were altered in both CD4 and CD8 T cells from 
infected CD2-Egr2/3−/− mice, some genes, including Csf1 
and Bcl6, were altered predominantly in CD4, whereas others, 
such as Gzmb, were mainly changed in CD8 cells (Fig. 6 C). 
The genes important in both CD4 and CD8 effector T cells, 
such as Ifng, Ccr5, Prdm1, Tbx21, Id3, Myc, and Myb, were 
up or down-regulated in both cell types (Fig. 6 C).
Recently, a kinetic study of the expression profiles of 
CD8 T cells from OT1 TCR transgenic mice during infec-
tion discovered distinct gene clusters that are associated with 
different stages and functions of the responding CD8 T cells 
(Best et al., 2013). We found that the genes down-regulated in 
Egr2- and Egr3-deficient T cells were predominantly among 
early-stage gene clusters with functions such as preparation 
for cell division and naive or late memory (Fig. 7 A), whereas 
up-regulated genes were mainly in later stages with functions 
in effector or effector and memory cells (Fig.  7 A). To fur-
ther confirm the differential expression of Egr2/3-regulated 
genes, CD44highGFP-Egr2high and CD44highGFP-Egr2low 
CD8 cells from viral infected GFP-Egr2 knock-in mice and 
CD8+Kb-SII NFE KL-tetramer+ cells from viral infected WT 
and CD2-Egr2/3−/− mice were analyzed for the expression 
of representative genes detected by RNA-seq. The expres-
sion of these genes in CD44highGFP-Egr2low CD8 cells and 
Egr2/3−/−CD8+Kb-SII NFE KL-tetramer+ cells was consis-
tent with their expression pattern in Egr2/3−/− CD8 T cells 
(Fig. 7 B). Thus, the up- and down-regulated gene profiles were 
consistent with the defects in T cells observed in CD2-Egr2/3−/− 
mice and the functions of Egr2high and Egr2low T cells from 
GFP-Egr2 knock-in mice in response to viral infection.
Egr2 binds to and controls the expression of 
transcription factors important for clonal expansion and 
effector differentiation
The altered transcription profiles in Egr2- and Egr3-deficient 
T cells showed bias toward genes involved in expansion and 
effector function and included key transcription factors regu-
lating proliferation and differentiation. Therefore, we analyzed 
the regulatory regions of these loci for potential binding sites 
for Egr2 using the programs Mulan and multiTF (Ovcha-
renko et al., 2005). Most loci had more than two potential 
binding sites in their regulatory regions. The potential bind-
ing sites were first assessed by electrophoretic mobility shift 
assay (EMSA) with probes derived from the potential binding 
sites as competitors for the interaction of Egr2 with its DNA 
consensus sequence (Ogbe et al., 2015). We first confirmed 
that Egr2 induced in naive CD4 T cells effectively bound to 
its DNA consensus sequence (Fig. 8 A). EMSA results showed 
that Egr2 from CD4 T cells of WT mice bound to most of 
the predicted sites (Fig. 8 A). The interactions were further 
validated by chromatin immunoprecipitation (ChIP) assays 
with primers flanking the binding sites (Fig. 8, B and C). In 
addition to direct interaction with the Bcl6 locus (Ogbe et al., 
2015), we found that Egr2 directly bound to the Myc, Myb, 
Tcf7, Id3, Ascl2, and Lef1 loci, genes that were down-regulated 
in Egr2- and Egr3-deficient T cells, and also to the Bhlhe40, 
Rora, Rorc, and Zeb2 loci, which were up-regulated in 
Egr2- and Egr3-deficient T cells in response to viral infec-
tion (Fig. 8, B and D). Consistent with the altered expression 
of these transcription factors, several of their target genes in 
Egr2- and Egr3-deficient T cells were also altered in the same 
fashion (Figs. 8 D and 6 B), indicating that Egr2 and 3 are 
upstream of specific transcription factors that are function-
ally important for proliferation and differentiation. Moreover, 
we confirmed binding of Egr2 to loci encoding transcription 
factors involved in Tfh development (Ascl2, Lef1, and Tcf7) 
that were down-regulated in Egr2- and Egr3-deficient CD4 
T cells (Fig. 8, B and C), which extends our previous findings 
that Egr2 and 3 are important for Tfh development (Ogbe et 
al., 2015). Bhlhe40, Rora, Rorc, and Zeb2 are transcription 
factors essential for differentiation of cytotoxic CD8 and Th1 
and Th17 CD4 cells (Kaech and Cui, 2012; Lin et al., 2014; 
Dominguez et al., 2015; Omilusik et al., 2015), and we have 
shown that they are directly regulated by Egr2. Thus, Egr2 
and 3 are upstream regulators of effector differentiation that 
promote Tfh cell differentiation while suppressing other ef-
fector functions. The “Egr2-centric” transcriptional network 
(Fig. 8 D and Table S1) highlights that Egr2 and/or 3 is an 
upstream regulator of early-stage adaptive responses by re-
etry. (B and C) Gated WT (CD45.1) and K2-3 (CD45.2) CD4 and CD8 cells were analyzed for expression of the activation marker CD44 and the proliferation 
marker Ki67 (left) and TNF and IFNγ for CD4 cells and granzyme B for CD8 cells (right). The percentages of Ki67+ cells among the CD44high population are 
indicated in parentheses in B. (D–G) WT and K2-3 OT1 retrogenic T cells were analyzed in recipient mice before and after infection. (D) GFP+CD8+CD44lo 
cells were isolated from WT and K2-3 OT1 retrogenic mice (left and middle) and confirmed as CD62L+Kb-SII NFE KL-tetramer+ cells (right). 3 × 105 to 5 × 105 
WT or Egr2/3−/− retrogenic-OT1 cells were adoptively transferred to separate naive WT mice. 1 d after transfer, mice were infected with OVA-VVWR and 
analyzed 7 d after infection. (E and F) Retrogenic-OT1 GFP+CD8+Kb-SII NFE KL-tetramer+ cells among spleen and lymph node cells from recipient mice were 
identified (E), and the numbers of WT and K2-3 retrogenic-OT1 cells in spleen and lymph nodes (left) and lung (right) were quantified (F). (G) Expression 
of proliferation and activation markers and production of effector cytokines by WT-retrogenic-OT1 and K2-3–retrogenic-OT1 cells gated as in E. The per-
centages of Ki67+ cells among the CD44high population are indicated in parentheses. Data are from pooled cells from four mice of each genotype and are 
representative of three (A–C) or two (D–G) independent experiments. Data in C and F are means ± SEM and were analyzed with Mann–Whitney two-tailed 
tests. *, P < 0.05; **, P < 0.01.
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Figure 5. Expression of Egr2 and 3 control the proliferation and differentiation of activated t cells in response to viral infection. (A) Genera-
tion of the GFP-Egr2 knock-in construct resulting in GFP fusion to the N terminus of Egr2. (B) PCR screening of homologous recombination with primers 
indicated in A. (C and D) CD4 T cells from spleen and lymph nodes of GFP-Egr2 knock-in mice (GFP-Egr2) and CD2-Egr2/3−/− (K2-3) mice were stimulated 
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ciprocally regulating proliferation and Tfh cell differentiation 
versus differentiation of cytotoxic and effector Th cells.
Expression of Egr2 and 3 in t cells is reciprocally 
regulated by antigen and IFnγ
The defects in differentiation of T cells from CD2-Egr2 
transgenic mice indicates that regulation of Egr2 and 3 ex-
pression is critical for optimal coupling of clonal expansion 
with differentiation of effector T cells. Analysis of Egr2 and 
3 expression in naive T cells demonstrated that Egr2 and 3 
were effectively induced by TCR stimulation, whereas their 
expression was suppressed by IFNγ (Fig. 9, A and B), suggest-
ing a feedback mechanism to counter the inhibitory effect of 
Egr2 and 3 on effector differentiation.
These findings suggest the intriguing possibility that 
Egr2 and 3 expression in T cells during the course of an im-
mune response may be temporally and repeatedly regulated 
based on changes in the microenvironment to adjust the level 
of expansion and differentiation. To assess this, we first kinet-
ically analyzed Egr2 and 3 expression in naive CD4 T cells 
after repeated 5-h TCR stimulation at 19-h intervals. Egr2 
and 3 were induced rapidly by initial stimulation (Fig. 9 C). 
After each interval, i.e., in the absence of TCR stimulation, 
Egr2 and 3 expression was completely abolished (Fig. 9 C). 
These results demonstrate that Egr2 and 3 expression in T 
cells is dependent on antigen stimulation.
Next we assessed regulation of Egr2 expression 
in vivo in response to viral infection. CD45.2+GFP- 
Egr2highCD44highCD8+ cells were isolated from GFP-Egr2 
mice 7 d after infection with OVA-VVWR and adoptively 
transferred into congenic CD45.1+ naive WT mice. The 
expression of Egr2 was assessed in recipients 5 and 48  h 
after transfer. Most Egr2high cells maintained their expres-
sion after 5  h, but all the cells became GFP-Egr2low after 
48 h (Fig. 9, D and E). 48 h after adoptive transfer, the re-
maining recipient mice were infected with OVA-VVWR, 
and Egr2-expressing T cells among transferred CD8 cells 
were analyzed 7 d after infection. The results demonstrated 
that Egr2 was reinduced during infection of recipient mice 
(Fig. 9, D and E). Notably, the percentage of CD8 cells ex-
pressing high levels of Egr2 was similar to that observed 
in donor mice under the same infection conditions, indi-
cating that Egr2 can be repeatedly induced after repeated 
exposure to antigens and that the level of each induction 
is based on the conditions in the microenvironment, not 
the expression level induced during previous induction. To 
further assess the temporal expression of Egr2 during viral 
infection, we isolated CD45.2+GFP-Egr2highCD44highCD8+ 
and CD45.2+GFP-Egr2lowCD44highCD8+ cells and adop-
tively transferred them to separate CD45.1+ naive mice. 
16 h after transfer, GFP-Egr2low cells remained GFP-Egr2low, 
whereas GFP-Egr2high were still largely GFP-Egr2high in 
recipient mice (Fig.  9  F). However, 7 d after infection of 
recipient mice, the percentage of T cells expressing high 
levels of GFP-Egr2 was similar in both groups (Fig. 9 F). 
In each of these groups, the expression of IFNγ was higher 
in GFP-Egr2low cells than in GFP-Egr2high cells (Fig. 9 G), 
consistent with the results from infection of GFP-Egr2 
mice (Fig. 5 I). Thus, the expansion and effector differenti-
ation of individual T cells can be adjusted by temporal Egr2 
and 3 expression in response to changes in the infected 
microenvironment to optimize responses until the patho-
gens have been eliminated.
dIscussIon
The expansion and differentiation of T cells in response to 
infection are highly regulated by external signals, including 
inflammatory stimuli and the levels of antigens and cytokines 
(Kaech et al., 2002; Williams and Bevan, 2007; Kaech and 
Cui, 2012), to achieve optimal adaptive immune responses 
(Stemberger et al., 2007; King et al., 2012; Tubo et al., 2013). 
We have now found that Egr2 and 3, induced in response to 
antigen stimulation, are required for clonal expansion while 
potently inhibiting the differentiation of effector T cells. 
This temporal uncoupling of expansion and differentiation, 
mediated by Egr2 and 3, is essential for sufficient expan-
sion of responding T cells and the control of pathology. We 
found that Egr2 and 3 expression is intricately regulated in 
a reciprocal fashion by antigen and inflammatory cytokines. 
The importance of proper regulation of Egr2 and 3 expres-
sion for adjusting expansion and differentiation is demon-
strated by the reciprocal impairments in CD2-Egr2/3−/− and 
CD2-Egr2 T cells. The failure to clear the virus in both 
CD2-Egr2/3−/− and CD2-Egr2 transgenic mice, despite ex-
cessive effector differentiation in the former and enhanced 
proliferation in the latter, demonstrates the importance of op-
timal coupling of expansion and differentiation of T cells in 
response to viral infection.
for 16 h with anti-CD3 and anti-CD28 in vitro and then analyzed for GFP-Egr2 expression by GFP and Egr2 staining (C) and for interaction of GFP-Egr2 
with its consensus DNA binding sequence by EMSA (D). (E) CD4 T cells from K2-3 mice were transduced with a GFP-Egr2-lentiviral expression construct. 
GFP-Egr2–positive and –negative cells were sorted and labeled with CellTrace Far-Red before stimulation with anti-CD3 and anti-CD28 in vitro for analysis 
of proliferation and production of IFNγ. (F–I) GFP-Egr2 knock-in mice were infected with OVA-VVWR i.n. and analyzed 7 d after infection. Splenic CD4 and 
CD8 cells were analyzed for GFP-Egr2 and CD44 expression (F), and gated CD44highGFP-Egr2high and CD44highGFP-Egr2low CD4 and CD8 cells were assessed 
for Ki67 expression (G). (H) CD44highGFP-Egr2high and CD44highGFP-Egr2low CD8 cells were isolated by cell sorting and incubated with OVA-VVWR–infected 
LB27.4 cells as antigen-presenting cells. Proliferation was measured after 72 h. (I) Expression of the indicated transcripts in isolated CD44highGFP-Egr2high 
and CD44highGFP-Egr2low T cells. C–E are representative of three independent experiments. Data in F–I are from pooled cells from four mice of each genotype 
and are representative of three independent experiments. Data in I are means ± SD. Data in H are means ± SEM and were analyzed with a Mann–Whitney 
two-tailed test. **, P < 0.01.
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Egr2 and 3 have an overlapping function in the reg-
ulation of the homeostasis of B and T cells (Li et al., 2012). 
Knockdown of Egr2 or Egr3 in established T cell lines renders 
T cells resistant to NFAT-mediated anergy in vitro (Harris et 
al., 2004), whereas Egr2 has been reported to regulate the 
function of Lag3-Treg cells (Okamura et al., 2009), indicating 
that Egr2 and 3 have important roles in T cell homeostasis. 
In contrast to their reported role in anergic T cells, we have 
demonstrated that Egr2 and 3 are required for clonal expan-
sion of naive T cells in antiviral responses. Collectively, these 
data indicate that the function of Egr2 and 3 in regulation of 
clonal expansion differs from their roles in NFAT-mediated 
anergy and Lag3-Treg cells (Harris et al., 2004; Okamura et 
al., 2009), demonstrating that distinct mechanisms regulate T 
cells under homeostatic conditions and during viral infection.
The novel function of Egr2 and 3 in reciprocal regu-
lation of proliferation and differentiation of naive T cells in 
adaptive immune responses is further extended by the intri-
Figure 6. Egr2 and 3 reciprocally regulate genes involved in proliferation and differentiation. Genome-wide mRNA expression profiling by RNA-seq 
was performed on CD44highGFP-Egr2highCD4+ and CD44highGFP-Egr2highCD8+ cells from GFP-Egr2 knock-in mice and CD44highCD4+ and CD44highCD8+ cells 
from CD2-Egr2/3−/− mice at day 7 after infection with VVWR. Differentially expressed genes were defined as ≥1.5-fold difference between the two groups 
with a false discovery rate of <0.05. (A) Genes differentially expressed between Egr2/3−/− and Egr2high CD4 and CD8 T cells were compared. (B) Heat map 
shows the mRNA expression of genes differentially expressed between GFP-Egr2 and Egr2/3−/− cells, in both CD4 and CD8 populations, with the individual 
experiments (Exp) and selected biologically relevant genes indicated. (C) Expression of selected genes in CD4 and CD8 cells. The RNA-seq data are from three 
biological replicates, each with three to five mice, for each group.
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cate and reciprocal regulation of Egr2 and 3 expression by an-
tigen and IFNγ. Reinduction of Egr2 and 3 after reencounter 
with antigen in vivo indicates that T cells can constantly ad-
just the extent of their proliferation and differentiation during 
the course of an infection, according to the levels of anti-
gens and inflammation. This intricate regulatory mechanism, 
whereby antigen and IFNγ regulate Egr2 and 3 expression, 
together with the function of Egr2 and 3 in controlling pro-
liferation and differentiation partly explains the profound 
diversity of individual T cells during an adaptive immune re-
sponse (Stemberger et al., 2007; King et al., 2012; Buchholz et 
al., 2013; Gerlach et al., 2013; Tubo et al., 2013).
Transcriptional profiling demonstrated that Egr2 and 3 
are upstream regulators of genes required for expansion and 
suppression of effector differentiation in both CD4 and CD8 
T cells in response to viral infection. Among the proliferation 
regulators, Egr2 and 3 directly control the expression of Myc 
in both CD4 and CD8 T cells in response to viral infection, 
which is a key transcription factor for T cell proliferation 
(Wang et al., 2011; Nie et al., 2012). In addition, Egr2 and 
3 also control several other proliferation regulators that are 
important for T cell proliferation such as Myb and Bcl9 (Lieu 
et al., 2004; Mani et al., 2009). Together with our previous 
findings that Egr2 can enhance AP1 activation mediated by 
mitogenic TCR signaling in vitro (Li et al., 2012), these data 
demonstrate that Egr2 and 3 are essential for clonal expansion 
of T cells in adaptive immune responses.
The unprecedented finding of uncoupling of clonal ex-
pansion and effector differentiation of Egr2 expressing CD4 
and CD8 T cells is associated with reciprocal regulation of re-
pressors and promoters of effector differentiation by Egr2 and 
3. In Egr2- and Egr3-deficient T cells, lineage-specific tran-
scription factors (Tbx21, Zeb2, Prdm1, Bhlhe40, Rora, Rorc, 
Runx2, and Runx3) for differentiation of cytotoxic CD8, 
Th1, and Th17 cells (Kaech and Cui, 2012; Lin et al., 2014; 
Dominguez et al., 2015; Omilusik et al., 2015) were highly 
expressed, whereas repressors (Id3 and Bcl6) of effector differ-
entiation (Shaffer et al., 2000; Yang et al., 2011) were defective. 
Among these altered genes, Egr2 directly bound to the Myc, 
Myb, Id3, Bcl6, Bhlhe40, Rora, Rorc, and Zeb2 loci, placing 
the function of Egr2 and 3 upstream of a network of tran-
scription factors regulating proliferation and differentiation.
The transcriptome analysis not only reveals Egr2- and 
Egr3-mediated pathways in T cells, but also identifies the 
stages of adaptive immune responses at which they act. A 
comparison with the transcriptional profiles of TCR trans-
genic naive CD8 T cells analyzed at different stages of an im-
mune response (Best et al., 2013), revealed that Egr2 and 3 
induce expression of genes mainly involved in preparation for 
proliferation at the early stages of infection while repressing 
genes required for effector differentiation. The distinctive 
representation of down-regulated and up-regulated genes 
from Egr2- and Egr3-deficient T cells into early proliferation 
and late differentiation gene clusters, respectively, demon-
strates that Egr2 and 3 expression defines a subset of cells that 
are about to proliferate after recent antigen encounter and 
that such cells are constantly being generated throughout the 
course of an infection.
T-bet is highly expressed in Egr2- and Egr3-deficient 
T cells in response to viral infection, which is in direct con-
Table 1. Examples of differentially expressed genes in Egr2- and Egr3-deficient t cells with key functions in t cells
Altered expression Cytokine Effector function Homing Proliferation Metabolism Transcription factors
Down-regulated Il2 Bcl6 Cxcr5 Bcl6 Tpi1 Bcl6
Il21 Tcf7 Ccr7 Bcl9 Pfkfb3 Tcf7
Il6ra Lef1 Bcl7a Adk Lef1
Il27ra Ascl2 Myc Ak4 Ascl2





Up-regulated Il1b Tbx21 Ccl8 Mxi1 Npc1 Tbx21
Il17a Zeb2 Cx3cr1 Mxd1 Upp1 Zeb2
Il23r Rora Ccl6 Crot Rora
Tnfrsf13c Rorc Ccl3 Xdh Rorc
Il18 Rara Ccl5 Rara
Il7r Runx2 Ccr2 Runx2
Csf1 Runx3 Ccl9 Runx3
Ifng Bhlhe40 Ccr6 Bhlhe40
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trast to a recent report that Egr2 is required for T-bet ex-
pression and that Egr2 deficiency leads to defects in both T 
cell activation and effector differentiation (Du et al., 2014). 
Although we could not explain the reason for the conflicting 
findings, we conclude that T-bet is not defective in Egr2- and 
Egr3-deficient T cells.
Figure 7. Egr2 and 3 regulated genes are important for early proliferation of t cells in response to infection. (A) Volcano plots of the entire 
RNA-seq dataset (gray) were overlaid with the indicated functional groups of genes (colors) previously defined in CD8 T cells at different stages of infec-
tion (Best et al., 2013), with positive and negative log2 fold changes indicating higher expression in GFP-Egr2 and CD2-Egr2/3−/− (K2-3) cells, respectively. 
(B) Key genes differentially expressed between GFP-Egr2 and K2-3 cells in the RNA-seq dataset show similar patterns in both CD44highGFP-Egr2highCD8+ and 
CD44highGFP-Egr2lowCD8+ cells from GFP-Egr2 knock-in mice (top) and CD8+Kb-SII NFE KL-tetramer+ cells from WT and CD2-Egr2/3−/− mice (bottom) 7 d after 
infection with OVA-VVWR. Data are means ± SD and are representative of three independent experiments (each with n = 10 mice/group).
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Figure 8. Egr2 binds to and regulates the expression of transcription factors involved in the proliferation and differentiation of t cells. 
(A) CD4 T cells from WT mice were stimulated for 16 h in vitro with anti-CD3 and anti-CD28 and nuclear proteins used for EMSA analysis. Probes derived 
from the potential Egr2-binding sites in the loci of the indicated transcription factors were used as competitors for the interaction of Egr2 with a labeled 
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Remarkably, despite suppressing effector differentia-
tion, Egr2 directly bound and promoted the expression of 
Tfh-related transcription factors (Bcl6, Lef1, Tcf7, and Ascl2), 
whereas the Tfh repressor Prdm1 was highly induced in 
Egr2- and Egr3-deficient CD4 T cells. These data are con-
sistent with and extend our previous findings of Egr2- and 
Egr3-mediated Tfh cell differentiation (Ogbe et al., 2015). 
Recently, it has been suggested that Tfh is an early state of ef-
fector differentiation (Nakayamada et al., 2011), which further 
supports an upstream function for Egr2 and 3 in program-
ming the early phase of T cell adaptive immune responses.
Egr2 and 3 are transiently expressed in naive T cells 
in response to acute viral infection, whereas the expression 
is sustained in chronic infection and tolerogenic conditions 
(Harris et al., 2004; Best et al., 2013; Stelekati et al., 2014). 
The sustained expression of Egr2 in T cells in lymphocytic 
choriomeningitis virus chronic infection is associated with 
defective effector function such as impaired production of 
IFNγ (Stelekati et al., 2014), suggesting that sustained expres-
sion of Egr2 and/or 3 caused by antigen persistence may be 
one of the mechanisms responsible for functional impairment 
of T cells in chronic infection.
Thus, regulation of the responses of individual T cells 
by Egr2 and 3, which themselves are regulated by the lev-
els of antigens and inflammation, provides a flexible, indi-
vidual, and intrinsic regulatory mechanism that determines 
the efficacy and pathology of an adaptive immune response. 
This novel function of Egr2 and 3, temporally induced by 
antigen while repressed by effector cytokines, is important 




Generation of the GFP-Egr2 allele is described in Fig.  5 
and the section below. GFP-Egr2 mice were backcrossed to 
C57BL/6 >10 times. GFP-Egr2 homozygous mice were used 
in this study. CD2-Egr2−/− (CD2-Cre/Egr2loxp/loxp), Egr3−/−, 
CD2-Egr2/3−/− (CD2-Cre/Egr2loxp/loxp/Egr3−/−), and CD2-
Egr2 transgenic mice were reported previously (Tourtellotte 
and Milbrandt, 1998; Zhu et al., 2008; Li et al., 2011, 2012) 
and were backcrossed to C57BL/6 more than 30 times. 
C57BL/6 mice purchased from Charles River were used as 
controls in all experiments. All mice analyzed were 7–8 wk of 
age. No animal was excluded from the analysis, and the num-
ber of mice used was consistent with previous experiments 
using similar experimental designs. All mice were maintained 
in the Biological Services Unit, Brunel University, and used 
according to established institutional guidelines under the au-
thority of a UK Home Office project license.
antibodies and flow cytometry
FITC-conjugated antibodies to B220 (11-0452-81, clone 
RA3-6B2), CD4 (11-0041-81, clone GK1.5), CD8 (11-
0081-81, clone 53-6.7), CD45.1 (11-0453-81, clone A20), 
IFNγ (11-7311-81, clone XMG1.2), and TCRβ (11-5961-
81, clone H57-597); PE-conjugated antibodies to CD3 
(12-0031-81, clone 145-2C11), CD4 (12-0041-81, clone 
GK1.5), CD8 (12-0081-81, clone 53-6.7), CD25 (12-0251-81, 
clone PC61.5), CD62L (12-0621-81, clone MEL-14), CD69 
(12-0691-81, clone H1.2F3), Ki-67 (12-5698-82, clone 
SolA15), Egr2 (12-6691-80, clone erongr2), and granzyme 
B (12-8898-80, clone NGZB); PerCP-labeled antibody to 
CD3 (45-0031-80, clone 145-2C11) and CD45.2 (45-0454-
80, clone 104); allophycocyanin (APC)-conjugated antibod-
ies to CD44 (17-0441-81, clone IM7), CD3 (17-0031-81, 
clone 145-2C11), TCRβ (17-5961-81, clone H57-597), Egr2 
(17-6691-82, clone erongr2), and TNF (17-7321-81, clone 
MP6-XT22); and PEcy7-conjugated antibody to CD44 (25-
0441-81, clone IM7) were obtained from eBioscience. PE- 
labeled anti-mouse TCR Vβ5.1, 5.2 (139504, clone MR9-4) 
was purchased from BioLegend. Antibody to CD3 (557306, 
clone 145-2C11) and CD28 (557393, clone 37.51) for stim-
ulation and 7AAD were obtained from BD. FITC- and APC- 
labeled MHC/peptide tetramers consisting of H2Kb MHC 
molecules bearing OVA 257-264 SII NFE KL peptides were 
obtained from the NIH Tetramer Core facility (Emory Uni-
versity, Atlanta, GA). For flow cytometry analysis, single-cell 
suspensions were analyzed on a LSR II or Canto (BD), and the 
data were analyzed using FlowJo (Tree Star). Cell sorting was 
performed on a FAC SAria sorter with DIVA option (BD).
cell isolation and stimulation
Naive CD4+ T cells were purified by negative selection 
using a MACS system (Miltenyi Biotec) or isolated by 
sorting CD25−CD4+CD44highCD62L− and CD25−CD4+ 
CD44lowCD62L+ T cells by FACS after staining with FITC- 
conjugated CD4, PE-conjugated CD62L, PEcy7-conjugated 
CD44, and APC-conjugated CD25 antibodies. Cells 
were gated on CD25− cells to exclude activated cells and 
Tregs. CD4+CD44highCD62L−GFP-Egr2high, CD4+CD44high 
CD62L−GFP-Egr2low, CD8+CD44highCD62L−GFP-Egr2high, 
probe containing its consensus binding sequence. Unlabeled probe containing the AP-1 consensus sequence served as negative control, and unlabeled Egr2 
consensus sequence served as positive control. The specificity of the band was confirmed by supershift. Nuclear proteins from stimulated CD2-Egr2/3−/− 
(K2-3) CD4 T cells served as a further negative control. (B and C) ChIP assay of anti-Egr2 precipitates from anti-CD3 and anti-CD28 stimulated CD4 T cells 
from WT mice. Total chromatin extracts from the same cells were used as positive controls, and IgG precipitates served as negative controls. ChIP data are 
presented as the percentage recovery of input in C. (D) Model of the “Egr2-centric” gene expression network in T cells in response to viral infection. Nodes 
are colored according to the level of expression in K2-3 cells in the RNA-seq data (Fig. 6), and those with a red border are direct Egr2 target genes. A–C are 
representative of three independent experiments. Data in C are means ± SD.
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Figure 9. Egr2 and 3 expression is repeatedly temporally regulated by tcr signaling in activated t cells. (A and B) Naive CD4 and CD8 T cells 
were stimulated with the indicated stimuli for 16 h before analysis of GFP-Egr2 expression (A) or Egr3 expression by RT-PCR (B). (C) Naive CD4 T cells were 
repeatedly stimulated with 2 µg/ml anti-CD3 and 2 µg/ml CD28 for 5 h with 19-h intervals over a 3-d period. Egr2 MFI was analyzed by flow cytometry, and 
Egr3 expression was analyzed by RT-PCR, before and after each interval. (D and E) CD44highGFP-Egr2highCD45.2+ CD8 T cells from GFP-Egr2 knock-in mice 7 d 
after infection were sorted and adoptively transferred into CD45.1+ WT mice. Recipient mice were infected with OVA-VVWR i.n. 48 h after transfer. Recipients 
were analyzed for Egr2 expression 5 or 48 h after transfer or 7 d after viral infection, as indicated. (F and G) CD44highGFP-Egr2highCD8+ and CD44highGFP- 
Egr2lowCD8+ cells were isolated from CD45.2+GFP-Egr2 knock-in mice after infection with OVA-VVWR for 7 d and then adoptively transferred into CD45.1+ 
WT mice. (F) GFP-Egr2 expression was examined 16 h after transfer or 7 d after OVA-VVWR infection. (G) IFNγ expression by CD44highGFP-Egr2highCD8+ cells 
and CD44highGFP-Egr2lowCD8+ cells isolated from infected recipient mice was analyzed by RT-PCR. Data in B and G are means ± SD, and data in C and E are 
means ± SEM. Data in A–C are representative of three independent experiments. Data in D–G are from pooled cells from four to five mice in each group and 
are representative of three independent experiments.
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and CD8+CD44highCD62L−GFP-Egr2low T cells from virus- 
infected mice were sorted by FACS. CD8+ T cells from 
infected mice were isolated by antibody-coated beads 
using MACS. Purified CD4+ T cells were stimulated with 
plate-bound anti-CD3 at 5 µg/ml or the indicated concen-
trations and anti-CD28 antibodies (2 µg/ml) for the indi-
cated times. Recombinant murine IFNγ (R&D Systems) 
was added where indicated.
CD8 T cells were stimulated in vitro with LB27.4 cells, 
which are B cell hybridoma cells that express both MHC 
class I and II proteins of the H-2 b haplotype (Antoniou and 
Watts, 2002). These cells were maintained in DMEM supple-
mented with 10% FCS, 2 mM l-glutamine, and antibiotics. 
Cells were routinely tested for mycoplasma contamination. 
Cells were infected with OVA-VVWR at a multiplicity of in-
fection of ∼5 and harvested between 8 and 12 h after infec-
tion. Cells were then resuspended in complete RPMI 1640 
and used to stimulate CD8 cells at a ratio of 0.5:1 LB27.4/T 
cells unless otherwise stated.
For analysis of Egr2 expression, the cells were processed 
using the Foxp3 staining kit (eBioscience). For analysis of 
cytokine-producing cells, the cells were stimulated with 50 
ng/ml PMA and 200 ng/ml ionomycin in the presence of 
Golgistop (BD) for 3 h before analysis of cytokine-producing 
cells by flow cytometry.
Proliferation
GFP-Egr2–transduced cells were labeled with CellTrace 
Far-Red reagent (Invitrogen). The cells were stimulated for 
72 h with 5 µg/ml anti-CD3 and 2 µg/ml anti-CD28 before 
analysis by flow cytometry.
Purified CD8 cells (5 × 104) were incubated with 
OVA-VVWR–infected LB27.4 cells at 1:1 or 1:5 ratios in 96-
well plates in triplicate for 48 h. A total of 1 µCi of [3H]TdR 
was added for the last 8 h of culture, and the cells were then 
harvested and subjected to scintillation counting to mea-
sure [3H]TdR incorporation.
Generation of constructs
All PCR cloning steps were performed with Pfx polymerase, 
and all constructs were confirmed by sequencing.
GFP-Egr2 knock-in construct
A BAC clone (MGC mouse RP23-88D4) containing 
the Egr2 gene was obtained from Source Bioscience. The 
Egr2-targeting construct was cloned from this BAC clone 
in two parts: a 5′ BamHI fragment and a 3′ BglII fragment 
(Fig.  5  A). The 5′ fragment of the Egr2 gene (3 kb) was 
cloned by PCR with the following primers: sense 5′-AAT 
CGC GGA TCC TCG CTG CTCC-3′ and antisense 5′-AAT 
CGC GGA TCC TGG TAG AGA TCT CCT-3′; digested with 
BamHI; and inserted into a pBlueScript vector. The resulting 
construct was modified by site-directed mutagenesis to insert 
an NdeI site just after the start codon of the Egr2 gene via 
PCR with the following primers: sense 5′-AGG TTG TGC 
GAG GAG CAA ATG ATG CAT ATG GTG AGC AAG GGC 
GA-3′ and antisense 5′-TCG CCC TTG CTC ACC ATA 
TGC ATC ATT TGC TCC TCG CAC AAC CT-3′. The CDS 
of GFP was cloned by PCR to contain NdeI sites with the 
following primers: sense 5′-AAT GAT GCA TAT GGT GAG 
CAA GGG CGA GG-3′ and antisense 5′-TTG GCG GTC ATA 
TGA TCT GAG TAC TTG TAC AGC-3′, and inserted into 
the Egr2 pBlueScript construct. The 3′ fragment of Egr2 (7 
kb) was cloned by PCR with the following primers: sense 
5′-AAT CGC AGA TCT CTA CCA GGA TCC TTC AGC-3′ 
and antisense 5′-AAT CGC AGA TCT GTC GTT TAA ACA 
AAT TTT TTT GTT GCT ATT GG-3′; digested with BglII; 
and inserted into a pBlueScript vector. To enable positive se-
lection after transfection, the Neomycin cassette was inserted 
at a NheI site downstream of the Egr2 ORF. The 3′ frag-
ment of Egr2 with Neomycin was inserted into the BglII site 
on the pBlueScript construct containing the 5′ fragment of 
Egr2. To enable negative selection after transfection, the her-
pes simplex virus thymidine kinase (TK) cassette was inserted 
at a SacII site on the pBlueScript vector downstream of the 
3′ fragment of Egr2. The plasmid was linearized with PciI for 
transfection of C57BL JM8ES cells. After karyotyping, two 
positive clones were used for blastocyst injection by Genetic 
Manipulation Services, Francis Crick Institute (Herts, UK). 
Chimeras were backcrossed more than 10 times to C57BL/6, 
and germline transmission was confirmed by genotyping 
with primers P1, 5′-TTG GGC GTT TGA AGT AAT GG-3′ 
(long product sense, outside targeting construct); P2, 5′-GCT 
CAG TTC AAC CCC TCT CC-3′ (short product sense); and 
P3, 5′-GGA TTT TGT CTA CGG CCT TG-3′ (common anti-
sense). Expression of GFP-Egr2 in T cells was confirmed by 
flow cytometry and immunoblotting with both anti-GFP 
and anti-Egr2 antibodies.
Quantitative real-time Pcr
Total RNA was extracted from cells using TRIzol (Invi-
trogen) and reverse transcribed using random primers (In-
vitrogen). Quantitative real-time PCR was performed on a 
Rotor-Gene system (Corbett Robotics) using SYBR green 
PCR master mix (QIA GEN). The primers used are as follows: 
Egr2, sense 5′-CTT CAG CCG AAG TGA CCA CC-3′ and 
antisense 5′-GCT CTT CCG TTC CTT CTG CC-3′; Egr3, 
sense 5′-GCT CTT CCG TTC CTT CTG CC-3′ and antisense 
5′-CGG TGT GAA AGG GTG GAA AT-3′; Il2, sense 5′-GCA 
TGT TCT GGA TTT GAC TC-3′ and antisense 5′-CAG 
TTG CTG ACT CAT CAT CG-3′; Ifng, sense 5′-CCA TCA 
GCA ACA ACA TAA GC-3′ and antisense 5′-AGC TCA TTG 
AAT GCT TGG CG-3′; Gzmb, sense 5′-GAC CCA AAG ACC 
AAA CGT GC-3′ and antisense 5′-TGA AAG CAC GTG GA 
G GTG AA-3′; Ccr5, sense 5′-GGA GGT GAG ACA TCC GT 
T CC-3′ and antisense 5′-GAA TAC CAG GGA GTA GAG T 
GGG-3′; Id3, sense 5′-ACA TGA ACC ACT GCT ACT CGC-3′ 
and antisense 5′-TGA GCT CAG CTG TCT GGA TCG-3′; 
Myc, sense 5′-GTA CCT CGT CCG ATT CCA CG-3′ and 
antisense 5′-GCT CTT CTT CAG AGT CGC TGC-3′; Myb, 
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sense 5′-CTG AAG ATG CTA CCT CAG ACCC-3′ and an-
tisense 5′-TCC CGA TTT CTC AGT TGG CG-3′; Prdm1, 
sense 5′-AAC CTG AAG GTC CAC CTG AG -3′ and anti-
sense 5′-TGC TAA ATC TCT TGT GGC AGAC-3′; Tcf7, sense 
5′-CCC AGC TTT CTC CAC TCT ACG-3′ and antisense 
5′-CTG TGA ACT CCT TGC TTC TGGC-3′; Tbx21, sense 
5′-CAT TGC AGT GAC TGC CTA CC-3′ and antisense 5′-
CAC TCG TAT CAA CAG ATG CG-3′; and Gapdh, sense 
5′-TGCACC ACC AAC TGC TTA GC-3′ and antisense 5′-GG 
C ATGGAC TGT GGT CAT GAG-3′.
The data were analyzed using the Rotor-Gene software. 
All samples were run in triplicate, and relative mRNA ex-
pression levels were obtained by normalizing against the level 
of Gapdh from the same sample under the same program 
according to relative expression = 2(CTgapdh − CTtarget).
Histological analysis
Tissues were fixed with 10% formalin in PBS and embed-
ded in paraffin. Sections were stained with hematoxylin and 
eosin (H&E). Histological examination of tissue sections was 
done in a blinded manner.
rna-seq analysis
RNA was isolated and purified using TRIzol reagent 
(Thermo Fisher Scientific). RNA concentration and integ-
rity were measured on a 2100 Bioanalyzer (Agilent Tech-
nologies). Only RNA samples with RNA integrity values 
>8.0 were considered for subsequent analysis. mRNA from 
T cells from independent experiments was processed for di-
rectional mRNA-seq library construction using the TruSeq 
Stranded mRNA Library Prep kit (Illumina) according to the 
manufacturer’s protocol. We performed 43-nt paired-end se-
quencing using an Illumina NextSeq platform and obtained 
∼40 million reads per sample. Base calls, demultiplexing, and 
adapter trimming were performed with Illumina software. 
The short sequenced reads were mapped to the mm10 build 
of the mouse reference genome using the spliced aligner 
Tophat (Kim et al., 2013). Intermediate processing steps to 
remove secondary alignments and pairs where only one read 
was mapped were performed using Samtools (Li et al., 2009). 
We used several R/Bioconductor (R Core Team, 2015) pack-
ages to identify genes differentially expressed between GFP-
Egr2 and Egr2/3−/− T cells. In brief, numbers of reads mapped 
to each gene on the basis of the refGene UCSC database 
were counted, reported, and annotated using the BiocParallel, 
Rsamtools, GenomicAlignments, GenomicFeatures, and org.
Mm.eg.db packages (Lawrence et al., 2013; Carlson, 2015; 
Morgan et al., 2015). Raw datasets have been submitted to the 
ArrayExpress database under accession no. E-MTAB-5338. 
To identify genes differentially expressed between groups, 
we used the R/Bioconductor package DESeq2 (Love et al., 
2014) with default parameters. In brief, count data were first 
normalized and dispersion estimated before a negative bino-
mial model was fitted with significance assessed by a Wald test. 
Resulting p-values were adjusted for multiple testing using 
the Benjamini–Hochberg procedure. Genes with an adjusted 
p-value ≤0.05 and an absolute fold change ≥1.5 were con-
sidered differentially expressed. The Venn diagram was created 
using the VennDiagram package (Chen, 2015).
Individual genes were plotted after normalization by 
sample read depth. For heat maps, a variance stabilizing trans-
formation from the DESeq2 and vsn packages (Huber et 
al., 2002; Love et al., 2014) was applied to the dataset, and 
differentially expressed genes identified were selected and 
row-centered by subtraction of the mean expression level for 
each gene before clustering with the Diana algorithm from 
the cluster package (Maechler et al., 2015) and visualization 
with the pheatmap package (Kolde, 2015).
For the comparison with the data from Best et al. (2013), 
the probeset affyIDs in each cluster were converted to Entrez 
ID and Gene symbol using the R/Bioconductor package 
biomaRt (Durinck et al., 2005, 2009). For the volcano plots, 
the data were modeled as ∼Cell type + Genotype to gen-
erate a single value for each gene. The resulting Benjamini– 
Hochberg corrected p-values and log2 fold changes for the 
total dataset were plotted using the ggplot2 and gridExtra 
packages (Wickham, 2009; Auguie, 2015) and then the genes 
in each cluster were overlaid as indicated.
For building the model of the Egr2-centric transcrip-
tional network, the direct Egr2 target genes identified in this 
study, together with their selected target genes from the liter-
ature, were visualized using Cytoscape (Shannon et al., 2003).
chIP assays
ChIP assays were performed according to the protocol sup-
plied with the kit (9003) from Cell Signaling Technology. In 
brief, 5 × 107 CD4 cells from WT mice were stimulated with 
anti-CD3 and anti-CD28 for 16 h. The cells were then cross-
linked with 1% formaldehyde for 10 min at room tempera-
ture. After quenching of formaldehyde with 125 mM glycine, 
chromatin was sheared by sonication with a Bioruptor Pico 
sonication system (Diagenode). The fragmented chromatin 
was ∼300–1,000 bp as analyzed on agarose gels. After pre-
clearing, chromatin (500 µg) was subjected to immunopre-
cipitation with specific anti-Egr2 antibody (eBioscience), 
or Ig as negative control, at 4°C overnight. Immunocom-
plexes were recovered by incubation with blocked protein 
G beads. DNA was purified according to the kit and used 
as template for PCR amplification in triplicate, with specific 
primers flanking the EMSA confirmed Egr2 binding sites. 
The primers used are as follows: Ascl2, sense 5′-TAC TCT 
ACA GGC ACC TCC AC-3′ and antisense 5′-AAT TGT CAT 
TGG CCA AAC GG-3′; Bhlhe40, sense 5′-CAG CCT CTG 
GAG AAG GCT AAGG-3′ and antisense 5′-GTT GGT AAC 
GTG GGC GAA CC-3′; Id3, sense 5′-GAG CGG AGT TAT 
CAG CTG GAGG-3′ and antisense 5′-GGG CTG GGT TAA 
GAT CGA AGC-3′; Lef1, sense 5′-CCC CTA GTC CCT AAT 
TCT CGCC-3′ and antisense 5′-TTG CCA GTC TTT CTT 
CAA CCT CC-3′; Myb, sense 5′-TGT CTC TAC CAC CCA 
CAT TTCC-3′ and antisense 5′-GGT TTG CTG GGA ATC 
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AAC ATG AGG-3′; Myc, sense 5′-CAA ATC CGA GAG CCA 
CAA CCC-3′ and antisense 5′-AGG ATT GCA AAA TGA 
CTA CAG CC-3′; Rora, sense 5′-CTG TGG GCT TAA ACC 
ATG TGT GC-3′ and antisense 5′-CCG TCA ATA AAT GCT 
TCC TGT GG-3′; Rorc, sense 5′-CTC CTG CTG CAA TGA 
TGA CACG-3′ and antisense 5′-AAA GAA AAC AAG CCG 
GGG ATG GG-3′; Tcf7, sense 5′-CAA CGC ATG TGA TCA 
CCC ACC-3′ and antisense 5′-TCC TGA AAG AAG AGG 
CGT CCG-3′; and Zeb2, sense 5′-TAT CAT GAG AAA GGC 
TGT GCC TGG-3′ and antisense 5′-ATG CCC AGC CTT 
CCA AGT TAA GG-3′. Data are expressed as the percentage 
of input DNA recovered.
EMsa
The consensus probe for Egr2 (5′-TGT AGG GGC GGG 
GGC GGG GTTA-3′) was labeled with Cyanine5 (Sigma-
Aldrich) and used in binding reactions with nuclear extracts 
from CD4 T cells stimulated with anti-CD3 and anti-CD28 
for 16  h. For supershift reactions, anti-Egr2 (eBioscience) 
was added after 10 min of incubation. The samples were 
electrophoresed on 5% polyacrylamide gels in 0.5× TBE. 
The gels were scanned using a Typhoon 9400 imager (GE 
Healthcare). For competition assays, oligos containing the 
Egr2 binding sites from each gene locus identified using 
Mulan (Ovcharenko et al., 2005) were added into the reaction 
mixtures before incubation. Probes used for competition 
assays are as follows: Ascl2 (chr7 :142969294 -142969318), 
5′-CCC TGG CGG AGG AGG CGG GAG CCGG-3′; Bhlhe40 
(chr6 :108660027 -108660047), 5′-GCC AGG CGG GGG 
AGG AGG AAG-3′; Id3 (chr4 :136144859 -136144882), 
5′-CTT CTC TCC TCC CCC GCC CAG AAC-3′; Lef1 (chr3 : 
131109827 -131109848), 5′-GGG GCT AGA GTG GGC GGC 
GGGA-3′; Myb (chr10 :21159419 -21159440), 5′-GGG CCC 
ACG CCC ACG CTC CTGC-3′; Myc (chr15 :61983490 
-61983511), 5′-GGG GGT GAG GGG GCG GGG AAAG-3′; 
Rora (chr9 :69243892 -69243913), 5′-GCT TGT TGT GTG 
GGA GGT GAGC-3′; Rorc (chr3 :94371792 -94371812), 
5′-GGA GGG AGT GGG CGA GTC ACG-3′; Tcf7 (chr11 
:52274904 -52274926), 5′-GGA CGT CCT CCC ACT CGC 
CCC TG-3′; and Zeb2 (chr2 :44979396 -44979420), 5′-CTG 
CCC TCC TCC ACC CCC TCC CCTG-3′.
lentiviral transduction
The lentiviral construct for GFP-Egr2 was generated by first 
creating a GFP-Egr2 fusion by insertion of the Egr2 CDS into 
the pEGFP-C3 vector and then transferring the GFP-Egr2 
fusion construct into the lentivirus transfer vector PRRL via 
the NdeI and XbaI sites. The construct was confirmed by se-
quencing. Lentivirus was produced by cotransfection of three 
plasmids, the transfer vector, envelope vector, and packaging 
vector, into HEK293 cells and concentrated by ultracentrifu-
gation of the supernatant on the second day after transfection. 
Naive CD4 cells at 106 per well in a 24-well plate coated with 
anti-CD3 and anti-CD28 were infected with concentrated 
lentivirus at a multiplicity of infection of 50–100 (∼105–106 
transducing units/ng of p24) as previously described (Li et al., 
2012). The infected cells were incubated at 37°C for 7 h with 
gentle shaking before addition of 1 ml medium. The cells were 
harvested after 24 h, and the GFP-negative and -positive cells 
were isolated by cell sorting and used for functional analysis.
Viruses and infection
Stocks of vaccinia virus (strain Western Reserve) encoding 
OVA (OVA-VVWR) were grown using TK143 cells in T175 
flasks and infected at a multiplicity of infection of 0.5. Cells 
were harvested at 72  h, and virus was isolated by rapidly 
freeze-thawing the cell pellet three times in 5  ml DMEM 
containing 10% FCS as previously described (Ogbe et al., 
2015). Cell debris was removed by centrifugation. Clarified 
supernatant was frozen at −80°C as virus stock. OVA-VVWR 
stocks were titrated using TK143 cells.
Mice were infected i.n. with 2 × 105 PFU of OVA-
VVWR in 10  µl of physiological saline. The mice were 
weighed and observed for illness daily, as previously described 
(Sofra et al., 2009). In vivo replication of OVA-VVWR was 
examined by plaque assay on lung tissue samples which were 
removed, weighed, and ground with a mortar and pestle. 
Serial 10-fold dilutions of clarified supernatants were used 
to infect subconfluent monolayers of TK143 cells in trip-
licate in 24-well plates. The cells were fixed with formalin 
2 d after infection and stained with 2% crystal violet in 40% 
methanol, and plaques were counted under an inverted mi-
croscope (CK2; Olympus).
BM chimeras and ot1 retrogenic mice
BM was collected from CD2-Egr2/Egr3−/− (CD45.2+) or 
WT C57BL/6 (CD45.1+) mice. For each chimera, 20 × 106 
cells of a 1:1 mixture of CD2-Egr2/Egr3−/− and C57BL/6 
BM cells were transferred intravenously into lethally irra-
diated (two doses of 550 rad) WT C57BL/6 (CD45.1+) 
recipients. For OT1 retrogenic mice, the OTI-2A.
pMIG II construct, a gift from D. Vignali (plasmid 52111; 
Addgene; Holst et al., 2006a,b) was transfected into Phoe-
nix cells (Takara Bio Inc.) as described (Zhu et al., 2008). 
BM cells isolated from CD2-Egr2/Egr3−/− and WT 
C57BL/6 mice were cultured with IL-3, IL-6, and stem cell 
factor (BioLegend) and transduced with retroviral super-
natant from transfected Phoenix cells by spin transduction 
as described (Holst et al., 2006a; Bettini et al., 2013). The 
transduced cells were analyzed for expression of GFP by 
flow cytometry. If GFP expression was detected, the cells 
were transferred into lethally irradiated (two doses of 550 
rad) WT C57BL/6 recipients as described (Holst et al., 
2006a; Bettini et al., 2013). Recipient mice were allowed 
8 wk for reconstitution.
adoptive transfer
GFP+CD8+CD44low cells were isolated from WT and 
Egr2/3−/− OT1 retrogenic mice by FACS, and expression 
of CD62L and the OT1 TCR was confirmed by staining 
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with APC-labeled Kb-SII NFE KL-tetramer and anti-CD62L. 
3 × 105 to 5 × 105 WT and Egr2/3−/− retrogenic OT1 cells 
were adoptively transferred to separate naive C57BL/6 mice. 
24 h after transfer, the recipient mice were infected i.n. with 
2 × 105 PFU of OVA-VVWR.
statistics
To analyze the statistical significance of differences between 
groups, two-tailed Mann–Whitney tests, using the R package 
coin (Hothorn et al., 2008), or Kruskal–Wallis tests followed 
by pairwise comparisons using Conover tests, as implemented 
in the R package PMC MR (Pohlert, 2014), with Benjamini–
Hochberg correction for multiple comparisons were used as 
indicated. Student’s unpaired two-tailed t tests were used for 
in vitro experiments. Differences with a p-value <0.05 were 
considered significant.
online supplemental material
Dataset S1 lists the genes identified as differentially expressed 
between GFP-Egr2high and CD2-Egr2/3−/− cells. Table S1 
contains information used to construct the model of the 
“Egr2 centric” gene expression network in Fig. 8 D. The sup-
plemental materials are provided as Excel files.
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